These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 23111141)

  • 1. Characteristics and outcomes of patients with ST-segment elevation myocardial infarction excluded from the harmonizing outcomes with revascularization and stents in acute myocardial infarction (HORIZONS-AMI) trial.
    Fiocca L; Guagliumi G; Rossini R; Parise H; Musumeci G; Sirbu V; Lortkipanidze N; Yu J; Mihalcsik L; Vassileva A; Valsecchi O; Gavazzi A; Mehran R; Stone GW
    Am J Cardiol; 2013 Jan; 111(2):196-201. PubMed ID: 23111141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between ST-segment recovery and clinical outcomes after primary percutaneous coronary intervention: the HORIZONS-AMI ECG substudy report.
    Farkouh ME; Reiffel J; Dressler O; Nikolsky E; Parise H; Cristea E; Baran DA; Dizon J; Merab JP; Lansky AJ; Mehran R; Stone GW
    Circ Cardiovasc Interv; 2013 Jun; 6(3):216-23. PubMed ID: 23652600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between intraprocedural thrombotic events and adverse outcomes after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (a Harmonizing Outcomes With RevasculariZatiON and Stents in Acute Myocardial Infarction [HORIZONS-AMI] Substudy).
    Kirtane AJ; Sandhu P; Mehran R; McEntegart M; Cristea E; Brener SJ; Xu K; Fahy M; Généreux P; Wessler JD; Stone GW
    Am J Cardiol; 2014 Jan; 113(1):36-43. PubMed ID: 24169019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial.
    Kornowski R; Mehran R; Dangas G; Nikolsky E; Assali A; Claessen BE; Gersh BJ; Wong SC; Witzenbichler B; Guagliumi G; Dudek D; Fahy M; Lansky AJ; Stone GW;
    J Am Coll Cardiol; 2011 Aug; 58(7):704-11. PubMed ID: 21816305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial).
    Cox DA; Stone GW; Grines CL; Stuckey T; Zimetbaum PJ; Tcheng JE; Turco M; Garcia E; Guagliumi G; Iwaoka RS; Mehran R; O'Neill WW; Lansky AJ; Griffin JJ;
    Am J Cardiol; 2006 Aug; 98(3):331-7. PubMed ID: 16860018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention during on- versus off-hours (a Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial substudy).
    Cubeddu RJ; Palacios IF; Blankenship JC; Horvath SA; Xu K; Kovacic JC; Dangas GD; Witzenbichler B; Guagliumi G; Kornowski R; Dudek D; Stone GW; Mehran R
    Am J Cardiol; 2013 Apr; 111(7):946-54. PubMed ID: 23340031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial).
    Rene AG; Généreux P; Ezekowitz M; Kirtane AJ; Xu K; Mehran R; Brener SJ; Stone GW
    Am J Cardiol; 2014 Jan; 113(2):236-42. PubMed ID: 24176066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term prognosis of patients presenting with ST-segment elevation myocardial infarction with no significant coronary artery disease (from the HORIZONS-AMI trial).
    Larsen AI; Nilsen DW; Yu J; Mehran R; Nikolsky E; Lansky AJ; Caixeta A; Parise H; Fahy M; Cristea E; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Stone GW
    Am J Cardiol; 2013 Mar; 111(5):643-8. PubMed ID: 23261001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of in-hospital major bleeding on late clinical outcomes after primary percutaneous coronary intervention in acute myocardial infarction the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
    Suh JW; Mehran R; Claessen BE; Xu K; Baber U; Dangas G; Parise H; Lansky AJ; Witzenbichler B; Grines CL; Guagliumi G; Kornowski R; Wöhrle J; Dudek D; Weisz G; Stone GW
    J Am Coll Cardiol; 2011 Oct; 58(17):1750-6. PubMed ID: 21996385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes mellitus, myocardial reperfusion, and outcome in patients with acute ST-elevation myocardial infarction treated with primary angioplasty (from HORIZONS AMI).
    Brener SJ; Mehran R; Dressler O; Cristea E; Stone GW
    Am J Cardiol; 2012 Apr; 109(8):1111-6. PubMed ID: 22244381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of outcomes of patients with ST-segment elevation myocardial infarction with versus without previous coronary artery bypass grafting (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial).
    Nikolsky E; Mehran R; Yu J; Witzenbichler B; Brodie BR; Kornowski R; Brener S; Xu K; Dangas GD; Stone GW
    Am J Cardiol; 2013 May; 111(10):1377-86. PubMed ID: 23465098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of hemoglobin levels on long-term prognosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
    Wang CH; Jin XF; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Liu ZY; Xie HZ
    Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(42):3003-6. PubMed ID: 22333029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of left ventricular ejection fraction on clinical long-term follow-up outcomes in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
    Wang CH; Xie XJ; Fang Q; Zhang SY; Fang ZJ; Jiang XF; Xie HZ; Liu ZY; Shen ZJ
    Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):265-8. PubMed ID: 21418873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When is door-to-balloon time critical? Analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trials.
    Brodie BR; Gersh BJ; Stuckey T; Witzenbichler B; Guagliumi G; Peruga JZ; Dudek D; Grines CL; Cox D; Parise H; Prasad A; Lansky AJ; Mehran R; Stone GW
    J Am Coll Cardiol; 2010 Jul; 56(5):407-13. PubMed ID: 20650362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of mortality rates in women versus men presenting with ST-segment elevation myocardial infarction.
    D'Ascenzo F; Gonella A; Quadri G; Longo G; Biondi-Zoccai G; Moretti C; Omedè P; Sciuto F; Gaita F; Sheiban I
    Am J Cardiol; 2011 Mar; 107(5):651-4. PubMed ID: 21195375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic utility of left ventricular end-diastolic pressure in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Planer D; Mehran R; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Möckel M; Reyes SL; Stone GW
    Am J Cardiol; 2011 Oct; 108(8):1068-74. PubMed ID: 21798494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between angiographic dynamic and densitometric assessment of myocardial reperfusion and survival in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: the harmonizing outcomes with revascularization and stents in AMI (HORIZONS-AMI) trial.
    Brener SJ; Cristea E; Mehran R; Dressler O; Lansky AJ; Stone GW
    Am Heart J; 2011 Dec; 162(6):1044-51. PubMed ID: 22137078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of outcomes in patients with ST-segment elevation myocardial infarction discharged on versus not on statin therapy (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial).
    Larsen AI; Tomey MI; Mehran R; Nilsen DW; Kirtane AJ; Witzenbichler B; Guagliumi G; Brener SJ; Généreux P; Kornowski R; Dudek D; Gersh BJ; Stone GW
    Am J Cardiol; 2014 Apr; 113(8):1273-9. PubMed ID: 24576541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of postprocedural sustained ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention (from the HORIZONS-AMI Trial).
    Mehta RH; Yu J; Piccini JP; Tcheng JE; Farkouh ME; Reiffel J; Fahy M; Mehran R; Stone GW
    Am J Cardiol; 2012 Mar; 109(6):805-12. PubMed ID: 22196782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of patients treated with triple antithrombotic therapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial).
    Nikolsky E; Mehran R; Dangas GD; Yu J; Parise H; Xu K; Pocock SJ; Stone GW
    Am J Cardiol; 2012 Mar; 109(6):831-8. PubMed ID: 22196778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.